Jack is a Research Analyst at Vestal Point, where he primarily covers large-cap pharmaceutical companies. Prior to joining Vestal Point, he was an Investment Banking Associate at Leerink Partners (2021–2025), focusing on the biopharmaceutical sector. He graduated summa cum laude from the University of Notre Dame with a B.B.A. in Finance.